US Patent 7101971 Erythropoietin analog-human serum albumin fusion
Patent 7101971 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on September, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Harry M. Meade0
Ian Krane0
Michael Young0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+134 characters)
Article
Patent abstract
Erythropoietin analog-human serum albumin (EPOa-hSA) fusion protein and methods of making and using the fusion protein.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07101971 Erythropoietin analog-human serum albumin fusion US Patent 7101971 Erythropoietin analog-human serum albumin fusion
Infobox
Patent Number
071019710
Patent Number
71019710
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071019710
Date of Patent
September 5, 2006
0Patent Application Number
100814000
Date Filed
February 20, 2002
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07101971 Erythropoietin analog-human serum albumin fusion
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07101971
Date of patent
September 5, 2006
Patent application number
10081400
Date Filed
February 20, 2002
Patent primary examiner
Find more entities like US Patent 7101971 Erythropoietin analog-human serum albumin fusion
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.